US FDA Approves Alcon’s New Dry-eye Drug (May 28)

by Medscape • 2025/05/28 • 0 Comments

(This May 28 story has been corrected to say 'eye drop,' not 'liquid medication,' in paragraph 3 and to remove the picture)
Reuters Health Information

← Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease

Study Underscores Need for Eye Exam in Psych Disorders →

Post navigation